Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14612511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of p53 in determining sensitivity to radiotherapy

  2003influential reference
• Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function

  2002cited by this paper
• Fas Is Involved in the p53-Dependent Apoptotic Response to Ionizing Radiation in Mouse Testis1

  2002cited by this paper
• A matter of life and death.

  2002cited by this paper
• DNA damage is able to induce senescence in tumor cells in vitro and in vivo.

  2002cited by this paper
• Triggering caspase-independent cell death to combat cancer.

  2002cited by this paper
• Live or let die: the cell's response to p53

  2002cited by this paper
• IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

  2001cited by this paper
• A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain

  2001cited by this paper
• Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.

  2001cited by this paper
• The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.

  2000cited by this paper
• Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.

  2000cited by this paper
• Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.

  2000cited by this paper
• p53 promotes selection for Fas-mediated apoptotic resistance.

  2000influential reference
• Tumor Necrosis Factor-α and Fas Activate Complementary Fas-associated Death Domain-dependent Pathways That Enhance Apoptosis Induced by γ-Irradiation*

  2000cited by this paper
• Cytotoxic T Cells Specifically Induce Fas on Target Cells, Thereby Facilitating Exocytosis-Independent Induction of Apoptosis1

  2000cited by this paper
• Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice

  2000cited by this paper
• Cross-talk in cell death signaling

  2000cited by this paper
• IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells1 2

  2000cited by this paper
• Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

  2000cited by this paper
• IFN-gamma-dependent delay of in vivo tumor progression by Fas overexpression on murine renal cancer cells.

  2000cited by this paper
• Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment

  1999cited by this paper
• Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.

  1999cited by this paper
• p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells

  1999cited by this paper
• Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95

  1999cited by this paper
• Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

  1999cited by this paper
• A Critical Role for the RelA Subunit of Nuclear Factor κB in Regulation of Multiple Immune-response Genes and in Fas-induced Cell Death

  1999cited by this paper
• Radiosensitization and apoptosis

  1998cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis.

  1998cited by this paper
• p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

  1998cited by this paper
• Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

  1997cited by this paper
• Up‐regulation of Fas (CD95) in human p53wild‐type cancer cells treated with ionizing radiation

  1997cited by this paper
• Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

  1997cited by this paper
• Apoptosis and response to radiation: implications for radiation therapy.

  1997cited by this paper
• Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues.

  1996cited by this paper
• Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

  1995cited by this paper
• Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.

  1995cited by this paper
• Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

  1994cited by this paper
• Down‐regulation of wild‐type p53 activity interferes with apoptosis of IL‐3‐dependent hematopoietic cells following IL‐3 withdrawal.

  1994cited by this paper
• Immunohtstochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies

  1993cited by this paper
• Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?

  1993cited by this paper
• Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

  1992cited by this paper
• An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

  1992cited by this paper
• Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.

  1990cited by this paper
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

  1989cited by this paper

• Cell death, therapeutics, and the immune response in cancer.

  2023cites this paper
• Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review

  2021cites this paper
• The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature

  2021cites this paper
• Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer

  2020cites this paper
• The alleviation effect of iron on cadmium phytotoxicity in mangrove A. marina. Alleviation effect of iron on cadmium phytotoxicity in mangrove Avicennia marina (Forsk.) Vierh.

  2019cites this paper
• Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness

  2017cites this paper
• FTIR Microspectroscopy Probes Particle-Radiation Effect on HCT116 cells (p53+/+, p53–/–)

  2017cites this paper
• Heterogeneous Nuclear Ribonucleoprotein L is required for the survival and functional integrity of murine hematopoietic stem cells

  2016cites this paper
• Radiation response of head and neck squamous cell carcinoma using early markers of apoptosis and proliferation, utilising a microfluidic approach

  2016cites this paper
• The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences.

  2015cites this paper
• Building immunity to cancer with radiation therapy.

  2015cites this paper
• Ionizing Radiation: Toxicologic Action

  2015cites this paper
• Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation

  2015cites this paper
• The Immunogenic Effect of Local Radiation Therapy in a Murine Model of Mesothelioma

  2015cites this paper
• Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation

  2014cites this paper
• FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells

  2014cites this paper
• Assessing the effects of radiotherapy on head and neck squamous cell carcinoma using microfluidic techniques

  2013cites this paper
• Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis

  2012cites this paper
• Sub-Lethal Irradiation of Human Colorectal Tumor Cells Imparts Enhanced and Sustained Susceptibility to Multiple Death Receptor Signaling Pathways

  2012cites this paper
• Radiation-induced cell death mechanisms

  2010cites this paper
• Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model

  2010cites this paper
• Molecular biology: an early detector of oral cancers.

  2009cites this paper
• Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.

  2009cites this paper
• Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells

  2009cites this paper
• Resistance of mitochondrial p53 to dominant inhibition

  2008cites this paper
• N-Acetylphytosphingosine enhances the radiosensitivity of lung cancer cell line NCI-H460

  2008cites this paper
• Radiation Induced Cell Deaths

  2008cites this paper
• Targeted Radionuclide Tumor Therapy

  2008cites this paper
• The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.

  2007cites this paper
• Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts

  2007cites this paper
• Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer

  2007cites this paper
• Comparison of Cellular Metabolic Responses of 18F-FDG According to the Effect of β-Irradiation in p53 Wild and Deleted Cell Lines

  2007cites this paper
• Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research.

  2006cites this paper
• Experimental radioimmunotherapy and effector mechanisms

  2006cites this paper
• Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis

  2006cites this paper
• Enhanced induction of apoptosis by combined treatment of human carcinoma cells with X rays and death receptor agonists.

  2005cites this paper
• Untersuchungen zur Strahlensensitivität von

  2005cites this paper
• HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: An unexpected effect on TRAIL‐induced apoptosis

  2005cites this paper
• BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.

  2005cites this paper
• DNA cytometry of oral leukoplakia and oral lichen planus.

  2005cites this paper
• Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?

  2005cites this paper
• A highly conserved proapoptotic gene, IKIP, located next to the APAF1 gene locus, is regulated by p53

  2004cites this paper
• Sublethal Irradiation of Human Tumor Cells Modulates Phenotype Resulting in Enhanced Killing by Cytotoxic T Lymphocytes

  2004cites this paper
• APOPTÓZA ZPROST¤EDKOVANÁ DEATH RECEPTORY: ÚLOHA FASL A TRAIL P¤I SMRTI MALIGNÍCH BUNùK DEATH RECEPTORS-MEDIATED APOPTOSIS: ROLE OF FASL AND TRAIL IN CANCER CELLS KILLING

  2003cites this paper